Therapeutic implications of phosphoproteomics in molecular cancer diagnostics. Utility of [18F]FDG PET/CT in predicting pathological complete response to neoadjuvant therapy in breast cancer: A ...
Correlation of allele-specific HLA loss of heterozygosity in patients with cancer with driver mutations. Baseline heterogeneity of myeloid and stroma cells to predict pCR, baseline lymph node (LN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results